PE123899A1 - Formulacion que contiene un opioide en combinacion con un agonista alfa-adrenergico y su utilizacion como analgesico - Google Patents

Formulacion que contiene un opioide en combinacion con un agonista alfa-adrenergico y su utilizacion como analgesico

Info

Publication number
PE123899A1
PE123899A1 PE00102998A PE00102998A PE123899A1 PE 123899 A1 PE123899 A1 PE 123899A1 PE 00102998 A PE00102998 A PE 00102998A PE 00102998 A PE00102998 A PE 00102998A PE 123899 A1 PE123899 A1 PE 123899A1
Authority
PE
Peru
Prior art keywords
alpha
opioid
adrenergic agonist
formulation containing
analgesic
Prior art date
Application number
PE00102998A
Other languages
English (en)
Inventor
Johannes Schneider
Johannes Bartholomaus
Johanna Korioth
Jurgen Betzing
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of PE123899A1 publication Critical patent/PE123899A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

CARACTERIZADA PORQUE COMPRENDE a)ENTRE 1 �g Y 500 �g DEL AGONISTA O-ADRENERGICO TAL COMO CLONIDINA, APRACLONIDINA, GUANFACINA, GUANABENZ, METILDOPA, OXIMETAZOLINA, XILOMETAZOLINA, TERIZOLINA, ENTRE OTROS Y b)ENTRE 0,5 mg Y 50 mg DE UN OPIOIDE TAL COMO MORFINA, HIDROMORFONA, CODEINA, OXICODON, DIHIDROCODEINA, DEXTROPROPOXIFEN, TRAMADOL, ENTRE OTROS. LA COMPOSICION PUEDE SER UTIL PARA EL TRATAMIENTO ANALGESICO, EVITANDO LA PRODUCCION DE EFECTOS CIRCULATORIOS DE ORIGEN CENTRAL
PE00102998A 1997-11-11 1998-11-02 Formulacion que contiene un opioide en combinacion con un agonista alfa-adrenergico y su utilizacion como analgesico PE123899A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1997149724 DE19749724A1 (de) 1997-11-11 1997-11-11 Verwendung einer Kombination aus Opioid und alpha-adrenergem Agonisten in Schmerzmitteln

Publications (1)

Publication Number Publication Date
PE123899A1 true PE123899A1 (es) 1999-12-25

Family

ID=7848237

Family Applications (1)

Application Number Title Priority Date Filing Date
PE00102998A PE123899A1 (es) 1997-11-11 1998-11-02 Formulacion que contiene un opioide en combinacion con un agonista alfa-adrenergico y su utilizacion como analgesico

Country Status (5)

Country Link
AU (1) AU1665499A (es)
DE (2) DE19749724A1 (es)
PE (1) PE123899A1 (es)
WO (1) WO1999024023A2 (es)
ZA (1) ZA9810272B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
ATE291907T1 (de) * 1998-10-20 2005-04-15 Omeros Corp Spülende lösung und methoden zur hemmung von schmerzen und entzündungen
US20030087962A1 (en) 1998-10-20 2003-05-08 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
US7973068B2 (en) 1998-10-20 2011-07-05 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
PE20001396A1 (es) * 1999-01-18 2000-12-23 Gruenenthal Chemie Formulaciones medicamentosas retardadas que contienen una combinacion de un opioide o una sal fisiologicamente tolerables del mismo, un o-agonista
DE19938823A1 (de) * 1999-08-19 2001-02-22 Boehringer Ingelheim Pharma Medikamentöse Behandlung des Restless Leg Syndroms
US6572891B1 (en) 1999-10-23 2003-06-03 Alkaloid Ad Sublingual oral dosage form
AU7023200A (en) * 1999-10-23 2001-05-08 Alkaloid Ad Oral dosage form comprising a salt of morphine or a morphine derivative
US20070060501A1 (en) * 2005-08-30 2007-03-15 Khem Jhamandas Methods and therapies for potentiating a therapeutic action of an opioid receptor agonist and inhibiting and/or reversing tolerance to opioid receptor agonists
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
JP2010518086A (ja) * 2007-02-09 2010-05-27 デュレクト コーポレーション スフェンタニルおよびナロキソンを含む経口腔投与製剤
US20090246256A1 (en) * 2008-03-27 2009-10-01 Al-Ghananeem Abeer M Compositions and Methods for Transmucosal Delivery of Lofexidine
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
WO2013090278A2 (en) 2011-12-11 2013-06-20 Recro Pharma, Inc. Intranasal dexmedetomidine compositions and methods of use thereof
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
ES2694644T3 (es) 2012-05-02 2018-12-26 Orexo Ab Nueva composición de alfentanilo para el tratamiento del dolor agudo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635204A (en) * 1994-03-04 1997-06-03 Montefiore Medical Center Method for transdermal induction of anesthesia, analgesia or sedation

Also Published As

Publication number Publication date
ZA9810272B (en) 1999-05-10
AU1665499A (en) 1999-05-31
DE19758564A1 (de) 1999-08-26
DE19749724A1 (de) 1999-06-10
WO1999024023A2 (de) 1999-05-20
WO1999024023A3 (de) 1999-07-15

Similar Documents

Publication Publication Date Title
PE123899A1 (es) Formulacion que contiene un opioide en combinacion con un agonista alfa-adrenergico y su utilizacion como analgesico
UA41316C2 (uk) Трициклічні похідні піролу і фармацевтичний препарат
NZ319531A (en) An analgesic synergistic composition containing a sub-analgesic dose of a mu opioid agonist and a kappa-2 opiod agonist
BR0107869A (pt) Composições farmacêuticas eletrogiradas
HK1024865A1 (en) Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies
HUP0204163A2 (hu) Opioid agonistát és antagonistát tartalmazó szabályozott leadású készítmény és eljárás az előállítására
HU1500214D0 (hu) Opioid agonista és antagonista hatóanyagot tartalmazó gyógyszerkészítmény
KR900701252A (ko) 코로 투약하는 벤조디아제핀 최면제
ES2157307T3 (es) Composicion topica que contiene un antagonista de sustancia p.
PL347671A1 (en) Compounds and compositions for delivering active agents
EP0783299A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
GT199700009A (es) Terapia combinada para la osteoporosis.
FI973828A (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
RS49982B (sr) Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
BR0012082A (pt) Formulação farmacêutica para administração compreendendo morfina e seu uso
CO5640086A2 (es) Formulacion agonistas opioide con antagonistas liberables y secuestrados
GB2335357A (en) Chitosan-gelatin A microparticles
IL153297A0 (en) Compounds and compositions for delivering active agents
BR9809057A (pt) Composições antitussìgenas
DK1124535T3 (da) Konserverende system til topisk indgivelige farmaceutiske præparater indeholdende en fedtsyre/aminosyresæbe
CA2325739A1 (en) Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a nmda receptor complex modulator
WO2001085150A3 (en) Opioid antagonist containing composition for enchaching the potency or reducing adverse side effects ofopioid agonists
SE9300012D0 (sv) New peptides
BR0008468A (pt) Método para fertilização humana in vitro, uso de um hormÈnio hipotalânico e/ou hormÈnio pituitário ou de um agonista ou antagonista do mesmo ou de um derivado ativo do mesmo, kit farmacêutico em forma de dosagem única, e, qualquer novo aspecto ou combinação de aspectos
BR0309057A (pt) Formulações lìquidas com baixa dosagem em entecavir e uso

Legal Events

Date Code Title Description
FC Refusal